Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria
Information is very scarce on the prevalence of hepatitis-B virus (HBV) infection among blood donors and patients with human immunodeficiency virus (HIV) infection in Nigeria. Hepatitis-B surface antigen (HBsAg) ELISA was used to determined the prevalence of HBsAg among 175 blood donors (aged 20-40...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
2005-02-01
|
| Series: | Memorias do Instituto Oswaldo Cruz |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762005000100002 |
| _version_ | 1797756907970101248 |
|---|---|
| author | CJ Uneke O Ogbu PU Inyama GI Anyanwu MO Njoku JH Idoko |
| author_facet | CJ Uneke O Ogbu PU Inyama GI Anyanwu MO Njoku JH Idoko |
| author_sort | CJ Uneke |
| collection | DOAJ |
| description | Information is very scarce on the prevalence of hepatitis-B virus (HBV) infection among blood donors and patients with human immunodeficiency virus (HIV) infection in Nigeria. Hepatitis-B surface antigen (HBsAg) ELISA was used to determined the prevalence of HBsAg among 175 blood donors (aged 20-40 years) and 490 HIV-infected patients (aged 17-60 years) in Jos, Nigeria. Twenty-five (14.3%) of the blood donors and 127 (25.9%) of the HIV-infected individuals were HBsAg seropositive, indicating a higher HBV infection among HIV-infected persons than among healthy blood donors. A slightly higher HBsAg seroprevalence was recorded in the males (14.6%) than females (12.9%) of the blood donors. Among the HIV-infected patients, the males had considerably higher HBsAg seroprevalence than the females (31.8 vs 22.1%) with the highest prevalence of HBsAg occurring in the 51-60 years age group (44%), followed by those of 31-40 years (28.2%). Results confirmed the high endemicity of HBV infection in Jos, Nigeria and the significantly greater prevalence of HBV infection among HIV -infected patients than among blood donors. |
| first_indexed | 2024-03-12T18:08:17Z |
| format | Article |
| id | doaj.art-52bb541ec96d4e37b24b0393b60b5875 |
| institution | Directory Open Access Journal |
| issn | 0074-0276 1678-8060 |
| language | English |
| last_indexed | 2024-03-12T18:08:17Z |
| publishDate | 2005-02-01 |
| publisher | Fundação Oswaldo Cruz (FIOCRUZ) |
| record_format | Article |
| series | Memorias do Instituto Oswaldo Cruz |
| spelling | doaj.art-52bb541ec96d4e37b24b0393b60b58752023-08-02T09:25:54ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602005-02-011001131610.1590/S0074-02762005000100002Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, NigeriaCJ UnekeO OgbuPU InyamaGI AnyanwuMO NjokuJH IdokoInformation is very scarce on the prevalence of hepatitis-B virus (HBV) infection among blood donors and patients with human immunodeficiency virus (HIV) infection in Nigeria. Hepatitis-B surface antigen (HBsAg) ELISA was used to determined the prevalence of HBsAg among 175 blood donors (aged 20-40 years) and 490 HIV-infected patients (aged 17-60 years) in Jos, Nigeria. Twenty-five (14.3%) of the blood donors and 127 (25.9%) of the HIV-infected individuals were HBsAg seropositive, indicating a higher HBV infection among HIV-infected persons than among healthy blood donors. A slightly higher HBsAg seroprevalence was recorded in the males (14.6%) than females (12.9%) of the blood donors. Among the HIV-infected patients, the males had considerably higher HBsAg seroprevalence than the females (31.8 vs 22.1%) with the highest prevalence of HBsAg occurring in the 51-60 years age group (44%), followed by those of 31-40 years (28.2%). Results confirmed the high endemicity of HBV infection in Jos, Nigeria and the significantly greater prevalence of HBV infection among HIV -infected patients than among blood donors.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762005000100002hepatitis B virushuman immunodeficiency virusblood donorprevalence |
| spellingShingle | CJ Uneke O Ogbu PU Inyama GI Anyanwu MO Njoku JH Idoko Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria Memorias do Instituto Oswaldo Cruz hepatitis B virus human immunodeficiency virus blood donor prevalence |
| title | Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria |
| title_full | Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria |
| title_fullStr | Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria |
| title_full_unstemmed | Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria |
| title_short | Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria |
| title_sort | prevalence of hepatitis b surface antigen among blood donors and human immunodeficiency virus infected patients in jos nigeria |
| topic | hepatitis B virus human immunodeficiency virus blood donor prevalence |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762005000100002 |
| work_keys_str_mv | AT cjuneke prevalenceofhepatitisbsurfaceantigenamongblooddonorsandhumanimmunodeficiencyvirusinfectedpatientsinjosnigeria AT oogbu prevalenceofhepatitisbsurfaceantigenamongblooddonorsandhumanimmunodeficiencyvirusinfectedpatientsinjosnigeria AT puinyama prevalenceofhepatitisbsurfaceantigenamongblooddonorsandhumanimmunodeficiencyvirusinfectedpatientsinjosnigeria AT gianyanwu prevalenceofhepatitisbsurfaceantigenamongblooddonorsandhumanimmunodeficiencyvirusinfectedpatientsinjosnigeria AT monjoku prevalenceofhepatitisbsurfaceantigenamongblooddonorsandhumanimmunodeficiencyvirusinfectedpatientsinjosnigeria AT jhidoko prevalenceofhepatitisbsurfaceantigenamongblooddonorsandhumanimmunodeficiencyvirusinfectedpatientsinjosnigeria |